drugset
drugset / Trial / NCT01430117

Biological Standardization of Poa Pratensis Allergen Extract

NCT01430117 ↗

Phase 2 Completed 31 enrolled Laboratorios Leti, S.L.
NaSingle-groupOpen-labelDiagnostic

Summary

The objective of this study is to determine the biologic activity of a Poa pratensis allergen extract in histamine equivalent prick (HEP) units, in order to be used as in-house reference preparation (IHRP).

Timeline

Start
2011-10
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Poa pratensis allergen extract Unknown — Other
Background Histamine Small molecule 10 mg/ml Other

Indications

allergic disease